Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro

Figure 1

MRI images of a 52-year-old female patient who underwent two operations with an interval of 6 months because of the rapid relapse of her tumor. A, The primary tumor located in the right temporal lobe and pathologically diagnosed as mixed glioma composed of anaplastic ependymoma and astrocytoma (WHO grade III). B, Post-operation image showing nearly total resection of the tumor. C, D, Relapse occurring 6 months later in situ and the ipsilateral frontal lobe; the recurrent lesion had transformed and progressed into glioblastoma multiforme (WHO grade IV).

Back to article page